below the two Drake’s and Lynch’s types, the expense of deleterious mutations is what drives mutation costs down (Drake 1991; Lynch 2010; Sung et al. 2012). for that reason, beneath the two versions, a rise in the normal expense of mutations would lead to a decrease in mutation rates. To examine thi